SCHEMBL5793121

SCHEMBL5793121

O=c1cnc2ccccc2n1-c1cc[nH]c1

nearest known ligand 0.42

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 11/20 0.42
KDM4E B2RXH2 10/20 0.42
HPGD P15428 3/20 0.42
HSD17B10 Q99714 6/20 0.40
TSHR P16473 3/20 0.40
LMNA P02545 1/20 0.40
NPSR1 Q6W5P4 1/20 0.39
TDP1 Q9NUW8 3/20 0.37
KMT2A Q03164 2/20 0.37
MEN1 O00255 1/20 0.37
CYP1A2 P05177 2/20 0.37
MAPT P10636 2/20 0.37
MAPK1 P28482 2/20 0.37
GMNN O75496 1/20 0.37
CYP3A4 P08684 1/20 0.37
CYP2C9 P11712 1/20 0.37
ALOX12 P18054 1/20 0.37
NFKB1 P19838 1/20 0.37
APEX1 P27695 1/20 0.37
SMN1; SMN2 Q16637 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL30050771 0.80 ALDH1A1 (0.53) ALDH1A1KDM4EHPGDHSD17B10TSHR
SCHEMBL10944497 0.80 ALDH1A1 (0.53) ALDH1A1KDM4EHPGDHSD17B10TSHR
SCHEMBL4889518 0.75 ALDH1A1 (0.55) ALDH1A1KDM4EHPGDHSD17B10TSHR
SCHEMBL30139979 0.75 ALDH1A1 (0.55) ALDH1A1KDM4EHPGDHSD17B10TSHR
SCHEMBL11392451 0.75 HDAC6 (0.47) ALDH1A1KDM4EHPGDHSD17B10TSHR
SCHEMBL7374554 0.73 ALDH1A1 (0.42) ALDH1A1KDM4EHPGDHSD17B10TSHR
SCHEMBL27150961 0.72 ALDH1A1 (0.47) ALDH1A1KDM4EHPGDHSD17B10TSHR
SCHEMBL29662040 0.72 ALDH1A1 (0.58) ALDH1A1KDM4EHPGDHSD17B10TSHR
SCHEMBL28505268 0.72 ALDH1A1 (0.58) ALDH1A1KDM4EHPGDHSD17B10TSHR
SCHEMBL31228793 0.71 KDM4E (0.40) ALDH1A1KDM4EHPGDHSD17B10TSHR

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1723146-A1 FUSED PYRAZOLE DERIVATIVES AS TGF-BETA SIGNAL TRANSDUCTION INHIBITORS FOR THE TREATMENT OF FIBROSIS AND NEOPLASMS ELI LILLY AND COMPANY (US) 2006-11-22 EP disclosed
WO-2005092894-A1 FUSED PYRAZOLE DERIVATIVES AS TGF-BETA SIGNAL TRANSDUCTION INHIBITORS FOR THE TREATMENT OF FIBROSIS AND NEOPLASMS ELI LILLY AND COMPANY (US) 2005-10-06 WO disclosed